Sign in

Filings

Finds words inside filing documents. Searching EXELIXIS, INC.'s filings · 28 documents indexed.

14 documents · 26 matches

  1. EXEL EXELIXIS, INC. 10-K 2026-02-10

    Item 1A. Risk Factors.

    tariffs on many goods imported from specified nations. In addition, there are currently discussions concerning potential increased tariffs for pharmaceutical
    8 matches in this document

  2. EXEL EXELIXIS, INC. 10-Q 2025-05-13

    Item 1A. Risk Factors.

    tariffs, related to countries where we or our suppliers operate could result in increased costs for raw materials, components, or finished
    3 matches in this document

  3. EXEL EXELIXIS, INC. 10-Q 2026-10-29

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    tariffs of up to 100% on certain imported patented pharmaceuticals and pharmaceutical ingredients, subject to exceptions for companies that have
    2 matches in this document

  4. EXEL EXELIXIS, INC. 8-K 2026-10-29

    tariffs and the related uncertainty thereof; and other factors detailed from time to time under the caption “Risk Factors” in Exelixis
    1 match in this document

  5. EXEL EXELIXIS, INC. 10-Q 2026-08-05

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    tariffs of up to 100% on certain imported patented pharmaceuticals and pharmaceutical ingredients, subject to exceptions for companies that have
    2 matches in this document

  6. EXEL EXELIXIS, INC. 8-K 2026-08-05

    tariffs and the related uncertainty thereof; and other factors detailed from time to time under the caption “Risk Factors” in Exelixis
    1 match in this document

  7. EXEL EXELIXIS, INC. 10-Q 2026-05-05

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    tariffs of up to 100% on certain imported patented pharmaceuticals and pharmaceutical ingredients, subject to exceptions for companies that have
    2 matches in this document

  8. EXEL EXELIXIS, INC. 8-K 2026-05-05

    tariffs and the related uncertainty thereof; and other factors detailed from time to time under the caption “Risk Factors” in Exelixis
    1 match in this document

  9. EXEL EXELIXIS, INC. 8-K 2026-02-10

    tariffs and the related uncertainty thereof; and other factors detailed from time to time under the caption “Risk Factors” in Exelixis
    1 match in this document

  10. EXEL EXELIXIS, INC. 8-K 2026-01-12

    tariffs and the related uncertainty thereof; and other factors detailed from time to time under the caption “Risk Factors” in Exelixis
    1 match in this document

  11. EXEL EXELIXIS, INC. 10-Q 2025-11-04

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    growth in prices of, pharmaceuticals. Furthermore, the U.S. Presidential administration has suggested that it may impose tariffs on imported pharmaceuticals.
    1 match in this document

  12. EXEL EXELIXIS, INC. 8-K 2025-11-04

    tariffs and the related uncertainty thereof; and other factors detailed from time to time under the caption “Risk Factors” in Exelixis
    1 match in this document

  13. EXEL EXELIXIS, INC. 10-Q 2025-07-28

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    growth in prices of, pharmaceuticals. Further, the U.S. Presidential administration has suggested that it may impose tariffs on imported pharmaceuticals.
    1 match in this document

  14. EXEL EXELIXIS, INC. 8-K 2025-07-28

    tariffs and the related uncertainty thereof; and other factors detailed from time to time under the caption “Risk Factors” in Exelixis
    1 match in this document

Page 1 of 1 · 14 documents